They say that their business model is to acquire potential drugs via in-licensing agreements with its inventors, develop the projects in house and out-licensing if needed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.